Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia
- Conditions
- Acute Myeloid Leukemia
- Registration Number
- NCT01785953
- Lead Sponsor
- Azienda Ospedaliera San Giovanni Battista
- Brief Summary
The purpose of this study is evaluate patients with acute myeloid leukemia (\<=66 years), treated with conventional and experimental chemotherapy following allogeneic transplantation. THis patients have been enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital. The purpose of data collection is to assess, with retrospective analysis, the clinical outcome divided by risk class and evaluated in patients who achieve complete remission after induction therapy and consolidation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival 1 year Event-free survival 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Città della Salute e della Scienza di Torino
🇮🇹Torino, Italy